The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Aims Recent guidelines have recommended more wide-ranging indications for the use of
implantable cardioverter defibrillator (ICD) therapy, yet even more restrained previous …

Implantable cardioverter-defibrillators (ICDs) are generally reliable medical devices that
have the potential to add quality years of life for appropriate candidates. Indications for ICDs …

Sudden cardiac death is a major public health issue in Canada. However, despite the
overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in …

■ Die endgültige Entscheidung zur Implantation eines ICD sollte auf der Basis
evidenzbasierter Medizin unter Berücksichtigung des individuellen Patientenprofils erfolgen …

Background—Patients with resuscitated ventricular tachyarrhythmias (ventricular
tachycardia/ventricular fibrillation) benefit from implantable cardioverter-defibrillators (ICDs) …

Features the consensus statement issued by the North American Society of
Electrophysiology and Pacing, in conjunction with the American College of Cardiology …

Background—Whether patients with heart failure derive a benefit from therapy with
implantable cardioverter-defibrillators (ICDs) has been questioned. The purpose of this …

Importance Improvement in left ventricular ejection fraction (EF) to> 35% occurs in many
patients with reduced EF at baseline. To our knowledge, whether implantable cardioverter …

Background Large randomized trials demonstrated the beneficial effect of implantable
cardioverter-defibrillator (ICD) and cardiac resynchronization therapy–defibrillator (CRT-D) …